Key Record Dates Identifier: NCT03345836
Brief Title: A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Biologic Therapy

First Submitted : November 15, 2017
First Submitted that Met QC Criteria : November 15, 2017
First Posted : November 17, 2017

Last Update Submitted that Met QC Criteria : April 27, 2021
Last Update Posted : April 29, 2021